Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
International Journal of Clinical Oncology
|
January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
Taigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
Anticancer Research
|
November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Taigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan
Taigo Kato, Satoru Yumiba, Wataru Nakata, et al.
International Journal of Molecular Sciences
|
August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
Eisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.
BMC Urology
|
July 9, 2025
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer
Takuji Hayashi, Atsunari Kawashima, Takeshi Ujike, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 6, 2023
The Japanese Urological Association's clinical practice guidelines for urotrauma 2023
Akio Horiguchi, Masayuki Shinchi, Kenichiro Ojima, et al.
Cancer Science
|
March 15, 2021
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers
Eisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, et al.
Cancer Science
|
March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma
Yujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study
Akira Nagahara, Motohide Uemura, Mototaka Sato, et al.
Anticancer Research
|
January 31, 2025
Efficacy of Second-line Nivolumab <i>Versus</i> Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases
Gaku Yamamichi, Taigo Kato, Akihiro Yoshimura, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
International Journal of Clinical Oncology
|
January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
Taigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
Anticancer Research
|
November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Taigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan
Taigo Kato, Satoru Yumiba, Wataru Nakata, et al.
International Journal of Molecular Sciences
|
August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
Eisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.
BMC Urology
|
July 9, 2025
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer
Takuji Hayashi, Atsunari Kawashima, Takeshi Ujike, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 6, 2023
The Japanese Urological Association's clinical practice guidelines for urotrauma 2023
Akio Horiguchi, Masayuki Shinchi, Kenichiro Ojima, et al.
Cancer Science
|
March 15, 2021
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers
Eisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, et al.
Cancer Science
|
March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma
Yujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study
Akira Nagahara, Motohide Uemura, Mototaka Sato, et al.
Anticancer Research
|
January 31, 2025
Efficacy of Second-line Nivolumab <i>Versus</i> Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases
Gaku Yamamichi, Taigo Kato, Akihiro Yoshimura, et al.
Page
of 14